


There is no fund objective available from this fund manager.
| Name | % Net Assets |
|---|---|
| GlaxoSmithKline PLC | 6.4% |
| Royal Dutch Shell PLC | 6.1% |
| AstraZeneca PLC | 5.9% |
| British American Tobacco PLC | 5.4% |
| BT Group PLC | 5.3% |
| Unilever PLC | 3.9% |
| Imperial Tobacco Group PLC | 3.3% |
| Legal & General Group PLC | 3.1% |
| Compass Group PLC | 3.0% |
| BG Group PLC | 2.5% |
| Key | % Net Assets |
|---|---|
| 6.4% | |
| 6.1% | |
| 5.9% | |
| 5.4% | |
| 76.2% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 209.14p |
| Currency | GBP |
| Change | 0.56p |
| % | 0.27% |
| YTD change | 15.91p |
| YTD % | 8.23% |
| Fund Inception | 30/09/1985 |
|---|---|
| Fund Manager | n/a |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research